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Symptomatic perioperative venous
thromboembolism is a frequent complication in
patients with a history of deep vein thrombosis
Timothy K. Liem, MD, Thanh M. Huynh, MS, Shannon E. Moseley, BA, Renee C. Minjarez, MD,
Gregory J. Landry, MD, Erica L. Mitchell, MD, Thomas G. DeLoughery, MD, and
Gregory L. Moneta, MD, Portland, Ore
Objectives: Patients who undergo surgery are at risk for venous thromboembolism (VTE), and a history of prior deep vein
thrombosis (DVT) increases that risk. This study determined the incidence and risk factors for symptomatic perioperative
VTE in patients with a prior diagnosis of DVT.
Methods: All lower extremity DVTs, diagnosed between January 2002 and December 2006, were identified through a
vascular database. Patients who had subsequent surgery were reviewed. The following data were evaluated: location of
DVT, time interval between DVT and surgery, type of surgery, common clinical VTE risk factors, postoperative venous
duplex scans, computed tomography (CT) scans of the chest, and ventilation-perfusion scans.
Results: A total of 372 patients with prior DVT underwent 1081 subsequent surgical procedures. One hundred nine
patients undergoing 211 procedures had a follow-up venous duplex scan within 30 days after surgery. Of them, 46%
received an inferior vena caval (IVC) filter, and pulmonary emboli were diagnosed in 3 patients (<1%). Overall, 24% of
the patients developedDVT extension or new-site DVT in the perioperative period. Themedian time interval between the
original DVT and surgery was 1.5 weeks in patients with DVT recurrence and 4 weeks in patients without recurrence (P
.22, Mann–Whitney). High-risk surgeries were associated with a >three-fold increased risk for recurrence, when
compared with low-risk procedures (34% vs 11%; P  .009, 2). Perioperative VTE recurrence was not influenced by the
location of the original thrombus or other VTE risk factors.
Conclusion: In patients with prior DVT, perioperative symptomatic recurrence is common and is associated with high-risk
procedures. A longer time interval between a DVT episode and subsequent surgery may decrease the risk of recurrence,
but large clinical trials are needed to confirm this. Further prospective evaluations are needed to identify and treat patients
at greatest risk for recurrence. ( J Vasc Surg 2010;52:651-7.)Perioperative venous thromboembolism (VTE) is a
frequent complication in patients who undergo major sur-
gical procedures. The risk for thromboembolism is in-
creased in patients with advancing age, malignancy, inher-
ited and acquired thrombophilic conditions, and in those
patients who undergo certain higher-risk surgical proce-
dures (for example: total hip arthroplasty, total knee arthro-
plasty, and abdominal cancer operations).1 A history of
deep vein thrombosis (DVT) or pulmonary embolism (PE)
frequently is cited as a risk factor for subsequent recurrence
around the time of surgery. However, the incidence of
perioperative VTE recurrence in patients with a history of
lower extremity deep vein thrombosis is not well studied.
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doi:10.1016/j.jvs.2010.04.029In addition, the appropriate timing for surgery after an
initial episode of DVT or PE is not well understood. The
risk for recurrent VTE is thought to depend, in part, on
the time interval between the original DVT and the
subsequent surgery. The American College of Chest
Physicians (ACCP) has published a risk stratification re-
garding the perioperative management of antithrombotic
therapy in patients with recent VTE. Patients are classified
as high-risk for VTE recurrence if the surgery occurs within
3 months of the original DVT or PE. Moderate-risk pa-
tients are those who had the VTE episode between 3 and
12 months before surgery. Low-risk patients are those
whose original venous thrombosis occurred more than 12
months before surgery.2 The ACCP guidelines describe
these classifications as largely empiric, and they have not
been validated in clinical trials.
The purpose of this study was to determine the inci-
dence of symptomatic perioperative VTE recurrence in
patients with a history of lower extremity DVT. This study
also sought to identify if any clinical variables were associ-
ated with a higher risk of recurrent DVT or PE.
PATIENTS AND METHODS
This study was approved by the Institutional Review
Board at Oregon Health & Science University. All patients
with a DVT-positive lower extremity venous duplex scan
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ber 2006) were identified from a prospectively maintained
vascular laboratory database. Those patients who under-
went subsequent surgery and had a follow-up venous du-
plex scan within 30 days after surgery were selected for this
study. We then performed a retrospective medical record
review. The location of the original DVT, the time interval
between the DVT and subsequent surgery, and the type of
surgical procedure were recorded. DVT location was cate-
gorized according to the highest level of involvement (iliac,
femoral, popliteal, or tibial). The patient age, gender, med-
ical comorbidities, the type and duration of antithrombotic
therapy, the type and duration of VTE prophylaxis, and the
results of follow-up lower extremity venous duplex scans,
computerized tomography (CT) scans of the chest, venti-
lation-perfusion (V/Q) scans, and pulmonary angiograms
were also determined from the medical record and entered
into a database.
Perioperative methods of thromboprophylaxis were
also obtained from the medical records. These included
low-dose unfractionated heparin, low-molecular-weight
heparin, fondaparinux, vitamin-K antagonists, sequential
compression devices, and graduated compression stock-
ings. The preoperative placement of an inferior vena caval
(IVC) filter was included as a method of VTE prophylaxis.
The followingmedical comorbidities were recorded: diabe-
tes, renal insufficiency, congestive heart disease, chronic
obstructive pulmonary disease, active or recent malignancy
(within 6 months), and hyperlipidemia. The presence of
common risk factors for VTE (history of DVT or PE, recent
Table I. Surgical procedures classified into lower-risk vs h
Low VTE risk
Orthopedic Arthroscopy and arthroscopic surg
Hardware removal
Elective spine surgery
Lower extremity injuries below kn
Neurosurgical Elective spine surgery
Transphenoidal procedures
Shunt procedures
Biopsies
General surgical Laparoscopic procedures
Open procedures for benign disea
Urologic Cystoscopy
Transurethral surgery
Laparoscopic procedures
Gynecologic Laparoscopic procedures
Open procedures 30 min
Head and neck surgical Open procedures for benign disea
Other Aortic and lower extremity arteria
Plastic and reconstructive surgery
VTE, Venous thromboembolism.surgery, trauma, idiopathic nature of the DVT, tobaccouse, hormonal therapy, or recent postpartum state) was also
recorded.
Patients who had a follow-up lower extremity venous
duplex scan within 30 days after surgery were selected, and
these follow-up studies were compared with the preopera-
tive scan. The primary endpoint for this study was the
development of an ipsilateral DVT extension, new-site
ipsilateral or contralateral DVT formation, or PE. Ipsilat-
eral DVT extensions were defined as a venous thrombus in
at least one deep vein segment proximal or distal to the
original DVT.
The subsequent surgical procedures were classified into
lower VTE risk and higher VTE risk categories. Although
some procedures do stand out with regard to their associ-
ation with venous thromboembolic complications (total
hip arthroplasty, abdominal cancer operations), there are
no standard definitions across the various surgical disci-
plines that categorize surgeries into low-risk vs high-risk for
VTE. Therefore, we created a broad classification system
based, in part, on the ACCPs Evidence-Based Clinical
Practice Guidelines (8th Edition; Table I).1 The ACCP
Guidelines provide evidence-based recommendations regard-
ing VTE prophylaxis for 23 surgical and medical conditions,
spanning a variety of specialties. When the guidelines recom-
mended against the use of specific thromboprophylaxis other
than early and frequent ambulation, then that procedure was
classified as low-risk for VTE. When pharmacologic prophy-
laxiswas recommended, basedon the type of procedure alone,
then that procedure was classified as high-risk for VTE. The
ACCP Guidelines recommend mechanical prophylaxis alone
-risk for venous thromboembolism
High VTE risk
Hip arthroplasty
Knee arthroplasty
Hip fracture surgery
Pelvic reconstruction
Procedures requiring craniotomy
Surgery for central nervous malignancy
5 min
Open procedures for benign disease 45 min
Open procedures for malignancy
Bariatric surgery
Open surgery for malignancy
Open prostectomy
Renal surgery/transplantation
Radical cystectomy
Pelvic surgery
Urethral reconstruction
Open surgery for benign disease 30 min
Open surgery for malignancy
5 min Open procedures for benign disease 45 min
Open procedures for malignancy
nstruction Major lower extremity amputations
Open thoracic surgery
Coronary bypass surgeryigher
ery
ee
se 4
se 4
l recoonly in very few circumstances (patients at high risk for bleed-
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knee replacement patients).1
Some surgical categories are specific enough that they
require no further definitions to describe the procedure (for
example: coronary bypass surgery, elective total knee re-
placement). Other categories, such as abdominal surgery,
may include a wide range of major and minor surgical
procedures. The ACCP thromboprophylaxis guidelines do
not specify which abdominal surgeries place patients at
higher risk vs lower risk for VTE. In these instances, we
derived the criteria for “major surgical procedure” from the
clinical definitions used in recent large thromboprophylaxis
trials for abdominal surgery (open abdominal operation for
malignancy, or an operation with a duration 45 min-
utes).3,4 Procedures from other specialties, such as head
and neck surgery, had no criteria to define major vs minor
procedures. In these instances, we used similar clinical
criteria to define high-risk for VTE: open surgery for ma-
lignancy or duration of greater than 45 minutes.
We evaluated for any associations between the primary
endpoint (VTE recurrence) and the following clinical vari-
ables: medical comorbidities, VTE risk factors, administra-
tion of thromboprophylaxis, time interval since the original
DVT, and type of surgical procedure. The Mann–Whitney
test was used for ordinal and non-normally distributed
variables, such as the time interval between the original
DVT and the subsequent surgery. Fisher’s exact test (two-
tailed) or 2 analysis was used for categorical variables,
depending on the sample cell size. Multivariate logistic
regression analysis was also performed if univariate analysis
identified any significant associations. Significant P values
were  .05 (SPSS Software version 14.0, Chicago, Ill).
RESULTS
Over the 5-year study period between January 2002
and December 2006, 7283 lower extremity venous duplex
scans were performed, with 1731 scans positive for DVT.
Of these, 372 patients who tested positive for lower ex-
tremity DVT underwent 1081 subsequent surgical proce-
dures. A total of 109 patients, having 211 subsequent
surgical procedures, also had a follow-up venous duplex
scan performed within 30 days of the surgical procedure.
This latter group forms the basis of this study. Patient
characteristics are listed in Table IIa, and the anatomic
distribution of the original lower extremity DVTs is listed
in Table IIb. Overall, 24% of patients developed DVT
extension, new-site DVT, or PE in the perioperative pe-
riod. All of the recurrences, except for one, were propaga-
tions of the original DVT or a new-site DVT (13 proximal
DVT extensions, 3 distal extensions, 5 new-site contralat-
eral DVTs, and 5 multiple sites of recurrence). There were
two additional diagnoses of upper extremity DVT, but
these were not included in the statistical analysis.
Perioperative symptomatic pulmonary embolism was a
rare occurrence, diagnosed in only 1 of 109 patients.
Among the 263 other patients who did not receive a
postoperative duplex scan follow-up, there were two addi-
tional PEs diagnosed within 30 days after surgery, resultingin a total of three PE diagnoses out of a total of 372
patients. However, imaging studies for PE were not com-
monly performed. Only 31 patients underwent a CT angio-
gram of the chest within 30 days of surgery, and no patients
had ventilation-perfusion scans.
Overall, therapeutic anticoagulation was administered
in 85% of patients after the original lower extremity DVT
diagnosis. Patients who did not receive therapeutic antico-
agulation either had an isolated calf DVT (6%) or a contra-
indication to anticoagulation due to an increased risk for
bleeding (9%). Eighty-two percent of patients with isolated
calf DVT were treated with anticoagulation. When com-
paring patients with and without perioperative VTE recur-
rence, there were no significant differences in the percent-
age who received therapeutic anticoagulation for the
original DVT (2 test, P  .05).
The number of patients who were still receiving anti-
coagulation until the time of surgery was dependent upon
the time interval between the original DVT and the sur-
gery. Forty-eight percent of the patients who had surgery
Table IIa. Clinical characteristics of 109 patients with
prior lower extremity DVT who underwent subsequent
surgery
Patient characteristics Incidence (%)
Age (years  SD) 53  19
Gender 42% female: 58% male
Malignancy 21%
Diabetes 38%
Renal insufficiency 24%
Hypercholesterolemia 20%
Obesity 22%
Tobacco use 47%
Known thrombophilia 8%
Oral contraceptive/ hormonal
replacement
4%
Idiopathic DVT 12%
Trauma associated 28%
Median time interval between original
DVT and subsequent surgery
3 weeks
DVT, Deep vein thrombosis; VTE, venous thromboembolism.
There was no significant association between these clinical factors and VTE
recurrence.
Table IIb. The anatomic distribution of the original
lower extremity DVTs and the number of patients with
postoperative DVT extension, new-site DVT, or
pulmonary embolism
Original DVT
location
Total number
of patients
Number of patients
with perioperative
VTE recurrence (%)
Iliac 9 2 (22%)
Femoral 44 10 (23%)
Popliteal 14 4 (29%)
Tibial 42 10 (24%)
DVT, Deep vein thrombosis; VTE, venous thromboembolism.more than 12 months after the original DVT were still
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surgery between 3 and 12 months after the original DVT,
54% were still receiving anticoagulation. In patients who
had surgery less than 3 months after the original DVT, 95%
were still receiving therapeutic anticoagulation until the
time of surgery. Anticoagulation was temporarily discon-
tinued in all patients before surgery and restarted at variable
time intervals after surgery. Typically, this occurred several
days after surgery, when the surgeon deemed that the risk
for bleeding had diminished.
Forty-six percent of the 109 patients received an IVC
filter before surgery. Accurate data regarding other meth-
ods of pharmacologic or mechanical perioperative VTE
prophylaxis were limited, present in only 29% of the med-
ical records reviewed. In these patients, the most common
methods of perioperative pharmaco-mechanical thrombo-
prophylaxis, other than an IVC filter, were sequential com-
pression devices (21% of procedures) and low-molecular-
weight heparin (11% of procedures). Twenty-one percent
of patients who had perioperative VTE recurrence received
thromboprophylaxis, whereas 31% of patients who did not
have VTE recurrence received prophylaxis. However, this
difference was not statistically significant (P  .32).
The types of surgical procedures are listed in Table III.
The more commonly performed surgeries included major
and minor general surgical, orthopedic, neurosurgical, and
minor head and neck procedures. About half of the minor
head and neck surgeries were for tracheostomy tube place-
ment. The magnitude of the surgical procedure did affect
the incidence of developing a recurrent VTE (Fig 1).
Patients who underwent a high-risk procedure had a 34%
incidence of DVT recurrence or PE, whereas, patients who
underwent a low-risk procedure had an 11% incidence (P
.009). Using multivariate logistic regression analysis,
higher magnitude surgery was an independent predictor of
VTE recurrence (P  .035), with an odds ratio of 2.74
Table III. List of surgical procedures performed in 109
patients after the original diagnosis of lower extremity
DVT
Surgical category Number of procedures
Minor general surgical 69
Major general surgical 37
Minor orthopedic 33
Major orthopedic 20
Minor neurosurgical 16
Minor head and neck 12
Other 9
Major neurosurgical 5
Major urologic 4
Minor urologic 3
Major gynecologic 2
Major head and neck 1
Minor gynecologic 0
Total 211
DVT, Deep vein thrombosis.
The categories are listed in order of frequency.(confidence interval, 1.07-6.99).Most of the subsequent surgical procedures were per-
formed soon after the original DVT diagnosis. Fifty-one
percent of the surgeries were performed within 3 weeks,
71% were performed within 3 months, and 86% were
performed within 12 months of the original DVT. The
overall median time interval between the original lower
extremity DVT diagnosis and the surgical procedure was 3
weeks. The median time interval between the original DVT
and the subsequent surgery was 1.5 weeks in patients who
had VTE recurrence and 4 weeks in patients without recur-
rence (Fig 2). However, this difference was not statistically
significant (P  .22).
Table IIb also lists the incidence of recurrence based on
the location of the original thrombus. There was no statis-
tically or clinically significant difference in the rate of peri-
operative recurrence based on the location of the original
DVT. The incidence rates for VTE recurrence were 22%
Fig 1. The risk for venous thromboembolism (VTE) recurrence
in patients undergoing lower-risk vs higher-risk surgical proce-
dures.
Fig 2. The time interval between the original deep vein throm-
bosis and the subsequent surgery in patients with and without
venous thromboembolism (VTE) recurrence.when the original DVT was in the iliac vein, 23% for the
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tibial vein.
DISCUSSION
In September 2008, the Surgeon General released a
49-page Call to Action to prevent DVT and PE.5 Although
significant advances have occurred with regard to appropri-
ate VTE prophylaxis and treatment, this document identi-
fied that the primary reason why DVT and PE remain a
significant public health problem lies in the failure to con-
sistently implement evidence-based interventions in high-
risk patients. Patients with a history of DVT who undergo
subsequent surgery certainly qualify as being at risk for
recurrence. However, the incidence of perioperative VTE
in these patients has not been described previously. Our
current study demonstrated that the incidence of symp-
tomatic DVT propagation or new site DVT during the
perioperative period is significant (overall 24% in our
study).
This high rate is not dissimilar from other studies of
patients who undergo surgery. The prevalence of DVT in
patients who undergo major general, urologic, and gyne-
cologic surgical procedures without thromboprophylaxis
ranges from 15% to 40%.1 Those patients who undergo
major orthopedic procedures and major trauma patients
may have a prevalence that is even higher (40% to 60% and
40% to 80%, respectively). However, these numbers de-
scribe the overall rate of symptomatic and asymptomatic
DVTs. Our current study was retrospective in nature, and it
is likely that many of the patients who received a duplex
scan after surgery were having ongoing or recurrent symp-
toms. Therefore, it is probable that the total incidence of
symptomatic and asymptomatic DVT propagation or new-
site DVT was significantly higher than we reported.
The ACCP Consensus Statement provides guidelines
regarding the perioperative management of anticoagula-
tion in patients with prior VTE.1 Patients are stratified
according to the time interval between the original DVT or
PE and the subsequent surgery: 3 months is considered
high-risk, 3 to 12 months is considered moderate-risk, and
12 months is considered low-risk for perioperative VTE
recurrence. In our current study, the median time interval
between the original DVT and surgery was only 3 weeks,
and 71% of the surgeries were performed within 3 months
of the DVT. Therefore, the majority of our patients were in
the highest risk interval, and it is likely that most of these
patients were undergoing urgent surgical procedures in a
high-acuity setting. Supporting this notion is the fact that
28% of the original DVTs were in association with trauma,
and only 12% were considered idiopathic venous thrombo-
ses. These patients may not be an accurate reflection of a
more elective surgical population in whom surgery may be
delayed to decrease the potential for VTE recurrence.
When comparing patients based on time interval since
the lower extremity DVT, the median interval between the
DVT and surgery was 1.5 weeks for patients who had VTE
recurrence and 4 weeks for patients without recurrence.
This difference was not statistically significant (P  .22),and it is likely that the number of patients in this study was
too small to identify a significant difference. However, this
trend would support the ACCP guidelines, suggesting that
a longer time interval between the original DVT and sub-
sequent surgery will decrease the risk for recurrence. Be-
cause the time interval in our current study was relatively
short in the majority of patients, we were unable to identify
a specific interval beyond which the risk for recurrent VTE
would be significantly reduced. Until more prospective
data are available, ACCP perioperative risk stratification
intervals should be utilized.
Higher magnitude surgeries were associated with a
greater than three-fold increased risk for recurrence when
compared with lower-magnitude procedures (34% vs 11%).
Although these data could be used to support the notion
that procedure-specific risk stratification would be useful,
we would consider all patients with a recent lower extremity
DVT to be at high risk for perioperative recurrence. The
rate of VTE recurrence remained consistent, regardless of
the location of the original DVT (22% to 29%). This was
contrary to our original hypothesis that larger more prox-
imal DVTs would have a greater propensity to propa-
gate, or at least would be associated with more risk
factors for perioperative VTE occurrence. These data
suggest that patients with a recent history of lower ex-
tremity DVT, regardless of thrombus location, are at in-
creased risk for perioperative VTE recurrence and that
aggressive thromboprophylaxis is warranted.
There were several potential limitations with this study.
As a retrospective evaluation, we selected only patients who
had a postoperative venous duplex scan performed within
30 days of surgery (109 patients out of a total 372 DVT
patients who underwent surgery). It is likely that a signifi-
cant number of these patients underwent the duplex scan to
evaluate the persistence or recurrence of lower extremity
symptoms. Therefore, the 24% recurrence rate is an approx-
imation of the rate of symptomatic VTE recurrence.
Only 29% of patients (109 of 372) received a postop-
erative duplex scan within 30 days of surgery, and it is
possible that the 24% incidence may have overestimated the
true rate of VTE recurrence. However, numerous prospec-
tive studies regarding perioperative VTE prophylaxis have
demonstrated consistently that the numbers of patients
who develop asymptomatic DVT far outnumber the pa-
tients with symptomatic thrombosis. A recent large pro-
spective VTE prophylaxis trial for patients who underwent
total knee arthroplasty demonstrated that only 10% to 14%
of the total perioperative VTE events were symptomatic.6
Other prospective studies have shown that symptomatic
DVTsmay comprise as little as 3% to 8% of the total number
of DVTs in thromboprophylaxis trials.3,7,8 Therefore, the
24% rate seen in this current study is likely an underestimate
of the incidence of total perioperative VTE events. In
addition, the timing of the postoperative scan was variable,
ranging from postoperative day 2 to 30. If the only follow-
up scan was performed too early in the postoperative
course, then additional venous thrombotic complications
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the true incidence of perioperative DVT recurrence.
As a retrospective study, the data regarding appropriate
mechanical and pharmacologic thromboprophylaxis were
limited. Although we reviewed the operative notes, anes-
thesia records, perioperative nursing records, medication
administration records, and physician orders, the documenta-
tion regarding pharmacologic and mechanical thrombopro-
phylaxis administration was inconsistent. Physician orders and
nursing records were more likely to document the ordering
and administration of heparin or low-molecular-weight hep-
arin. However, there was no systematic documentation re-
garding the use of sequential compression devices.
Suboptimal usage of thromboprophylaxis is not an
uncommon problem. Several recent studies have docu-
mented a widely variable utilization of VTE prophylaxis in
patients hospitalized for medical illnesses and surgical pro-
cedures.9 Two large multi-institutional databases from the
United States demonstrated that the rate of using appro-
priate VTE prophylaxis ranged from 32.5% to 43.9% in
surgical patients.10,11 A larger multinational cross-sectional
study of over 68,000 patients documented that 58.5% of
at-risk surgical patients received VTE prophylaxis.12 Be-
cause the current study was retrospective, it is probable that
we were not able to identify all surgical patients who
received appropriate thromboprophylaxis, and our rate of
29% likely undercounts the total number.
IVC filters were placed in almost one-half of the pa-
tients before the subsequent surgery. This high rate of filter
insertion was probably appropriate in most of these pa-
tients, due to the short time interval between the original
DVT and the surgery (median of 3 weeks). During this time
period, most patients would otherwise be receiving anti-
thrombotic therapy, and a contraindication to anticoagula-
tion around the time of surgery is a valid indication for IVC
filter usage.13 It is also possible that the large number of
IVC filters placed in this study may have contributed to the
relatively low rate of symptomatic pulmonary embolisms.
However, this cannot be confirmed based on our data
alone.
Our classification system for procedure-specific VTE
risk remains to be fully validated. Although it is based on
the ACCP physician practice guidelines, there are some
surgical procedures that have not been studied with
regard to optimal perioperative VTE prophylaxis.1 In
these groups, our definition of high-risk surgery was ex-
trapolated from studies of patients who underwent major
abdominal surgery. In addition, there are some surgeries
for which the ACCP recommendations differ from guide-
lines published by other surgical specialties. For example,
the ACCP has recommended against the use of aspirin as
venous thromboprophylaxis for any patient group.1 How-
ever, the American Academy of Orthopedic Surgeons lists
aspirin as an acceptable option for prophylaxis against
symptomatic PE in selected patients who undergo total hip
or knee arthroplasty.14,15 In another example, the Society
of American Gastrointestinal and Endoscopic Surgeons
have published thromboprophylaxis guidelines that recom-mend mechanical and/or pharmacologic prophylaxis for
certain laparoscopic procedures, even when clinical VTE
risk factors are absent.16 This is in contrast to the ACCP
recommendations against the routine use of thrombopro-
phylaxis in lower-risk patients who undergo entirely lapa-
roscopic procedures.1
Since the time period of this study, a completely elec-
tronic medical record conversion has been implemented at
our institution, both for inpatient and outpatient settings.
In the process of completing the postoperative order set,
physicians and mid-level health care providers are required
to complete a mandatory electronic VTE prophylaxis strat-
ification. This requires that the provider stratify patients
into low risk, moderate risk, or high risk for perioperative
VTE. If the patient is at moderate or high-risk for VTE,
then the provider must choose an appropriate method of
mechanical and/or pharmacologic prophylaxis, or indicate
that the bleeding risk is too high to administer pharmaco-
logic prophylaxis. Kucher et al17 have demonstrated that
the use of a computer-alert program increases the utiliza-
tion of thromboprophylaxis and significantly reduces the
incidence of DVT and PE in at-risk hospitalized patients.
In summary, patients with lower extremity DVT who
undergo subsequent surgical procedures are at high risk for
developing symptomatic VTE recurrence. In this study, the
incidence of symptomatic PE was rare, perhaps related to
the frequent placement of IVC filters. Higher-magnitude
surgical procedures are associated with a significantly
higher incidence of DVT recurrence. In patients with re-
cent DVTs, delaying the performance of surgical proce-
dures may decrease the risk for perioperative VTE recur-
rence, but larger studies are needed to confirm this.
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